Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Shu, Chin Chung ^a,b   Wu, Vin Cent ^a,b   Yang, Feng Jung ^a   Pan, Sung Ching ^a   Lai, Tai Shuan ^a   Wang, Jann Yuan ^a,b   Wang, Jann Tay ^a,b   Lee, Li Na ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEMODIALYSIS; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERITONEAL DIALYSIS; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; SMOKING; TUBERCULOSIS;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; RENAL DIALYSIS; TAIWAN; TUBERCULOSIS;

EID: 84865187602     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042592     Document Type: Article

References (40)

1. Rose DN, ((2000)) Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med 160:: 1513--1521.
2. Christopoulos AI, Diamantopoulos AA, Dimopoulos PA, Gumenos DS, Barbalias GA, ((2006)) Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis. Int Urol Nephrol 38:: 745--751.
3. Dobler CC, McDonald SP, Marks GB, ((2011)) Risk of tuberculosis in dialysis patients: a nationwide cohort study. PLoS One 6:: e29563.
4. Lundin AP, Adler AJ, Berlyne GM, Friedman EA, ((1979)) Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 67:: 597--602.
5. Smirnoff M, Patt C, Seckler B, Adler JJ, ((1998)) Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 113:: 25--27.
6. Jick SS, Lieberman ES, Rahman MU, Choi HK, ((2006)) Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 55:: 19--26.
7. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49:: 1--51.
8. Venkata RK, Kumar S, Krishna RP, Kumar SB, Padmanabhan S, ((2007)) Tuberculosis in chronic kidney disease. Clin Nephrol 67:: 217--220.
9. Fang HC, Lee PT, Chen CL, Wu MJ, Chou KJ, et al. ((2004)) Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis 8:: 92--97.
10. Simsek H, Alpar S, Ucar N, Aksu F, Ceyhan I, et al. ((2010)) Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J Infect Dis 63:: 99--102.
11. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P, ((2004)) Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170:: 65--69.
12. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A, ((2008)) Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177:: 1164--1170.
13. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, et al. ((2009)) Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 24:: 1952--1956.
14. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, et al. ((2009)) High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 37:: 96--102.
15. Lee SS, Chou KJ, Dou HY, Huang TS, Ni YY, et al. ((2010)) High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 5:: 1451--1457.
16. Chung WK, Zheng ZL, Sung JY, Kim S, Lee HH, et al. ((2010)) Validity of interferon-gamma-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect 16:: 960--965.
17. Sester M, Sester U, Clauer P, Heine G, Mack U, et al. ((2004)) Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 65:: 1826--1834.
18. Stevens LA, Viswanathan G, Weiner DE, ((2010)) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17:: 293--301.
19. Hill CJ, Fogarty DG, ((2012)) Changing trends in end-stage renal disease due to diabetes in the United kingdom. J Ren Care 38 Suppl 1:: 12--22.
20. Shu CC, Wang JT, Lee CH, Wang JY, Lee LN, et al. ((2010)) Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study. BMC Infect Dis 10:: 48.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, ((1973)) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:: 646--649.
22. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, et al. ((2001)) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163:: 824--828.
23. Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, et al. ((2010)) Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 10:: 57.
24. Banach DB, Harris TG, ((2011)) Indeterminate QuantiFERON(R)-TB Gold results in a public health clinic setting. Int J Tuberc Lung Dis 15:: 1623--1630.
25. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation. Am J Kidney Dis 30:: S15--66.
26. Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K, ((2012)) Patterns and Predictors of Early Mortality in Incident Hemodialysis Patients: New Insights. Am J Nephrol 35:: 548--558.
27. Lin HH, Ezzati M, Chang HY, Murray M, ((2009)) Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 180:: 475--480.
28. Jasmer RM, Snyder DC, Chin DP, Hopewell PC, Cuthbert SS, et al. ((2000)) Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis. Am J Respir Crit Care Med 162:: 1648--1652.
29. Yu MC, Suo J, Huang C, Bai KJ, Lin TP, et al. ((1999)) Annual risk of tuberculous infection in Taiwan, 1996-1998. J Formos Med Assoc 98:: 496--499.
30. Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH, et al. ((2010)) Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 16:: 294--296.
31. Centers of Disease Control DoH, R.O.C. (Taiwan) (2010) CDC Annual Report 2011. Taipei: Centers of Disease Control, Department of Health, R.O.C. (Taiwan).
32. Wang JY, Shu CC, Lee CH, Yu CJ, Lee LN, et al. ((2012)) Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis. J Infect 64:: 291--298.
33. Shu CC, Wu HD, Yu MC, Wang JT, Lee CH, et al. ((2010)) Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 89:: 53--61.
34. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, et al. ((2007)) Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167:: 335--342.
35. Palomar R, Arias Guillen M, Robledo C, Aguero R, Aguero J, et al. ((2011)) Detection of latent tuberculosis infection in peritoneal dialysis patients: new methods. Nefrologia 31:: 169--173.
36. Chavers BM, Solid CA, Gilbertson DT, Collins AJ, ((2007)) Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol 18:: 952--959.
37. Lange B, Vavra M, Kern WV, Wagner D, ((2010)) Indeterminate results of a tuberculosis-specific interferon-gamma release assay in immunocompromised patients. Eur Respir J 35:: 1179--1182.
38. Fabrizi F, Dixit V, Martin P, Jadoul M, Messa P, ((2011)) Meta-Analysis: The Impact of Nutritional Status on the Immune Response to Hepatitis B Virus Vaccine in Chronic Kidney Disease. Dig Dis Sci 2012; 57:: 1366--1372.
39. de Cal M, Cruz DN, Corradi V, Nalesso F, Polanco N, et al. ((2008)) HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients. Blood Purif 26:: 249--254.
40. Vacher-Coponat H, Brunet C, Lyonnet L, Bonnet E, Loundou A, et al. ((2008)) Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol Dial Transplant 23:: 1406--1414.